| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abcellera Biologics Inc. (ABCL) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. ABCL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 56.13M | $270.57M | - | |
| CEO | 13.10M | $63.13M | - | |
| CFO | 8.75M | $42.18M | - | |
| Other | 5.20M | $25.07M | - | |
| Other | 4.65M | $22.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Thermopylae Holdings Ltd.63 | 10% Owner | Buy | 38,000 | $3.44 | $130,720.00 | - | - | - | |
| Nov 26, 2025 | Montalbano John S.52 | Director | Buy | 50,000 | $3.57 | $178,460.00 | +29.2% | -11.5% | - | |
| Mar 11, 2025 | Thermopylae Holdings Ltd.63 | 10% Owner | Buy | 343,631 | $2.16 | $742,242.96 | +0.6% | +12.6% | +63.7% | |
| Mar 10, 2025 | Montalbano John S.52 | Director | Buy | 25,000 | $2.30 | $57,500.00 | +17.1% | +14.1% | +62.7% | |
| Mar 6, 2025 | Montalbano John S.52 | Director | Buy | 60,000 | $2.34 | $140,568.00 | +69.8% | +1.7% | +45.4% | |
| Aug 29, 2024 | Thermopylae Holdings Ltd.63 | 10% Owner | Buy | 283,516 | $2.61 | $739,976.76 | +0.5% | +18.6% | +65.2% | |
| Nov 8, 2023 | Montalbano John S.52 | Director | Buy | 30,000 | $4.58 | $137,400.00 | +22.7% | +23.9% | -34.9% | |
| Sep 22, 2023 | Hayden Michael R58 | Director | Buy | 20,000 | $4.91 | $98,200.00 | +1.5% | +13.8% | -48.2% | |
| Sep 12, 2023 | Lecault Veronique48 | Chief Operating Officer | Buy | 20,000 | $5.19 | $103,800.00 | +1.0% | -6.8% | -47.7% | |
| Aug 8, 2023 | Hayden Michael R58 | Director | Buy | 30,000 | $5.90 | $177,000.00 | +2.4% | -24.0% | -55.3% |